Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Geriatric Care Services Market

ID: MRFR/MRO/65045-HCR
200 Pages
Shubham Munde
Last Updated: March 30, 2026

Geriatric Care Services Market Size, Share and Trends Analysis Research Report Information By Age Group (65-74, 75-84, 85+), By Service Type (Home Care, Adult Day Care, Nursing, Assisted Living), By Caregiver Type (Professional, Family, Volunteers), By Payment Source (Private, Medicare, Medicaid, Insurance), By Health Condition (Chronic Illness, Mobility, Cognitive, Mental Health), And By Region – Market Forecast Till 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Geriatric Care Services Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Service Type (USD Billion)
  49.     4.1.1 Home Care Services
  50.     4.1.2 Adult Day Care Services
  51.     4.1.3 Nursing Care Services
  52.     4.1.4 Assisted Living Services
  53.   4.2 Pharmaceutical, BY Caregiver Type (USD Billion)
  54.     4.2.1 Professional Caregivers
  55.     4.2.2 Family Caregivers
  56.     4.2.3 Volunteers
  57.   4.3 Pharmaceutical, BY Payment Source (USD Billion)
  58.     4.3.1 Private Pay
  59.     4.3.2 Medicare
  60.     4.3.3 Medicaid
  61.     4.3.4 Long-term Care Insurance
  62.   4.4 Pharmaceutical, BY Age Group (USD Billion)
  63.     4.4.1 65-74 Years
  64.     4.4.2 75-84 Years
  65.     4.4.3 85 Years and Older
  66.   4.5 Pharmaceutical, BY Health Condition (USD Billion)
  67.     4.5.1 Chronic Illness
  68.     4.5.2 Mobility Issues
  69.     4.5.3 Cognitive Impairment
  70.     4.5.4 Mental Health Issues
  71.   4.6 Pharmaceutical, BY Region (USD Billion)
  72.     4.6.1 North America
  73.       4.6.1.1 US
  74.       4.6.1.2 Canada
  75.     4.6.2 Europe
  76.       4.6.2.1 Germany
  77.       4.6.2.2 UK
  78.       4.6.2.3 France
  79.       4.6.2.4 Russia
  80.       4.6.2.5 Italy
  81.       4.6.2.6 Spain
  82.       4.6.2.7 Rest of Europe
  83.     4.6.3 APAC
  84.       4.6.3.1 China
  85.       4.6.3.2 India
  86.       4.6.3.3 Japan
  87.       4.6.3.4 South Korea
  88.       4.6.3.5 Malaysia
  89.       4.6.3.6 Thailand
  90.       4.6.3.7 Indonesia
  91.       4.6.3.8 Rest of APAC
  92.     4.6.4 South America
  93.       4.6.4.1 Brazil
  94.       4.6.4.2 Mexico
  95.       4.6.4.3 Argentina
  96.       4.6.4.4 Rest of South America
  97.     4.6.5 MEA
  98.       4.6.5.1 GCC Countries
  99.       4.6.5.2 South Africa
  100.       4.6.5.3 Rest of MEA
  101. 5 SECTION V: COMPETITIVE ANALYSIS
  102.   5.1 Competitive Landscape
  103.     5.1.1 Overview
  104.     5.1.2 Competitive Analysis
  105.     5.1.3 Market share Analysis
  106.     5.1.4 Major Growth Strategy in the Pharmaceutical
  107.     5.1.5 Competitive Benchmarking
  108.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  109.     5.1.7 Key developments and growth strategies
  110.       5.1.7.1 New Product Launch/Service Deployment
  111.       5.1.7.2 Merger & Acquisitions
  112.       5.1.7.3 Joint Ventures
  113.     5.1.8 Major Players Financial Matrix
  114.       5.1.8.1 Sales and Operating Income
  115.       5.1.8.2 Major Players R&D Expenditure. 2023
  116.   5.2 Company Profiles
  117.     5.2.1 Brookdale Senior Living (US)
  118.       5.2.1.1 Financial Overview
  119.       5.2.1.2 Products Offered
  120.       5.2.1.3 Key Developments
  121.       5.2.1.4 SWOT Analysis
  122.       5.2.1.5 Key Strategies
  123.     5.2.2 Amedisys (US)
  124.       5.2.2.1 Financial Overview
  125.       5.2.2.2 Products Offered
  126.       5.2.2.3 Key Developments
  127.       5.2.2.4 SWOT Analysis
  128.       5.2.2.5 Key Strategies
  129.     5.2.3 LHC Group (US)
  130.       5.2.3.1 Financial Overview
  131.       5.2.3.2 Products Offered
  132.       5.2.3.3 Key Developments
  133.       5.2.3.4 SWOT Analysis
  134.       5.2.3.5 Key Strategies
  135.     5.2.4 Visiting Angels (US)
  136.       5.2.4.1 Financial Overview
  137.       5.2.4.2 Products Offered
  138.       5.2.4.3 Key Developments
  139.       5.2.4.4 SWOT Analysis
  140.       5.2.4.5 Key Strategies
  141.     5.2.5 Comfort Keepers (US)
  142.       5.2.5.1 Financial Overview
  143.       5.2.5.2 Products Offered
  144.       5.2.5.3 Key Developments
  145.       5.2.5.4 SWOT Analysis
  146.       5.2.5.5 Key Strategies
  147.     5.2.6 Genesis HealthCare (US)
  148.       5.2.6.1 Financial Overview
  149.       5.2.6.2 Products Offered
  150.       5.2.6.3 Key Developments
  151.       5.2.6.4 SWOT Analysis
  152.       5.2.6.5 Key Strategies
  153.     5.2.7 Sunrise Senior Living (US)
  154.       5.2.7.1 Financial Overview
  155.       5.2.7.2 Products Offered
  156.       5.2.7.3 Key Developments
  157.       5.2.7.4 SWOT Analysis
  158.       5.2.7.5 Key Strategies
  159.     5.2.8 Kindred Healthcare (US)
  160.       5.2.8.1 Financial Overview
  161.       5.2.8.2 Products Offered
  162.       5.2.8.3 Key Developments
  163.       5.2.8.4 SWOT Analysis
  164.       5.2.8.5 Key Strategies
  165.     5.2.9 Home Instead (US)
  166.       5.2.9.1 Financial Overview
  167.       5.2.9.2 Products Offered
  168.       5.2.9.3 Key Developments
  169.       5.2.9.4 SWOT Analysis
  170.       5.2.9.5 Key Strategies
  171.   5.3 Appendix
  172.     5.3.1 References
  173.     5.3.2 Related Reports
  174. 6 LIST OF FIGURES
  175.   6.1 MARKET SYNOPSIS
  176.   6.2 NORTH AMERICA MARKET ANALYSIS
  177.   6.3 US MARKET ANALYSIS BY SERVICE TYPE
  178.   6.4 US MARKET ANALYSIS BY CAREGIVER TYPE
  179.   6.5 US MARKET ANALYSIS BY PAYMENT SOURCE
  180.   6.6 US MARKET ANALYSIS BY AGE GROUP
  181.   6.7 US MARKET ANALYSIS BY HEALTH CONDITION
  182.   6.8 CANADA MARKET ANALYSIS BY SERVICE TYPE
  183.   6.9 CANADA MARKET ANALYSIS BY CAREGIVER TYPE
  184.   6.10 CANADA MARKET ANALYSIS BY PAYMENT SOURCE
  185.   6.11 CANADA MARKET ANALYSIS BY AGE GROUP
  186.   6.12 CANADA MARKET ANALYSIS BY HEALTH CONDITION
  187.   6.13 EUROPE MARKET ANALYSIS
  188.   6.14 GERMANY MARKET ANALYSIS BY SERVICE TYPE
  189.   6.15 GERMANY MARKET ANALYSIS BY CAREGIVER TYPE
  190.   6.16 GERMANY MARKET ANALYSIS BY PAYMENT SOURCE
  191.   6.17 GERMANY MARKET ANALYSIS BY AGE GROUP
  192.   6.18 GERMANY MARKET ANALYSIS BY HEALTH CONDITION
  193.   6.19 UK MARKET ANALYSIS BY SERVICE TYPE
  194.   6.20 UK MARKET ANALYSIS BY CAREGIVER TYPE
  195.   6.21 UK MARKET ANALYSIS BY PAYMENT SOURCE
  196.   6.22 UK MARKET ANALYSIS BY AGE GROUP
  197.   6.23 UK MARKET ANALYSIS BY HEALTH CONDITION
  198.   6.24 FRANCE MARKET ANALYSIS BY SERVICE TYPE
  199.   6.25 FRANCE MARKET ANALYSIS BY CAREGIVER TYPE
  200.   6.26 FRANCE MARKET ANALYSIS BY PAYMENT SOURCE
  201.   6.27 FRANCE MARKET ANALYSIS BY AGE GROUP
  202.   6.28 FRANCE MARKET ANALYSIS BY HEALTH CONDITION
  203.   6.29 RUSSIA MARKET ANALYSIS BY SERVICE TYPE
  204.   6.30 RUSSIA MARKET ANALYSIS BY CAREGIVER TYPE
  205.   6.31 RUSSIA MARKET ANALYSIS BY PAYMENT SOURCE
  206.   6.32 RUSSIA MARKET ANALYSIS BY AGE GROUP
  207.   6.33 RUSSIA MARKET ANALYSIS BY HEALTH CONDITION
  208.   6.34 ITALY MARKET ANALYSIS BY SERVICE TYPE
  209.   6.35 ITALY MARKET ANALYSIS BY CAREGIVER TYPE
  210.   6.36 ITALY MARKET ANALYSIS BY PAYMENT SOURCE
  211.   6.37 ITALY MARKET ANALYSIS BY AGE GROUP
  212.   6.38 ITALY MARKET ANALYSIS BY HEALTH CONDITION
  213.   6.39 SPAIN MARKET ANALYSIS BY SERVICE TYPE
  214.   6.40 SPAIN MARKET ANALYSIS BY CAREGIVER TYPE
  215.   6.41 SPAIN MARKET ANALYSIS BY PAYMENT SOURCE
  216.   6.42 SPAIN MARKET ANALYSIS BY AGE GROUP
  217.   6.43 SPAIN MARKET ANALYSIS BY HEALTH CONDITION
  218.   6.44 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE
  219.   6.45 REST OF EUROPE MARKET ANALYSIS BY CAREGIVER TYPE
  220.   6.46 REST OF EUROPE MARKET ANALYSIS BY PAYMENT SOURCE
  221.   6.47 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
  222.   6.48 REST OF EUROPE MARKET ANALYSIS BY HEALTH CONDITION
  223.   6.49 APAC MARKET ANALYSIS
  224.   6.50 CHINA MARKET ANALYSIS BY SERVICE TYPE
  225.   6.51 CHINA MARKET ANALYSIS BY CAREGIVER TYPE
  226.   6.52 CHINA MARKET ANALYSIS BY PAYMENT SOURCE
  227.   6.53 CHINA MARKET ANALYSIS BY AGE GROUP
  228.   6.54 CHINA MARKET ANALYSIS BY HEALTH CONDITION
  229.   6.55 INDIA MARKET ANALYSIS BY SERVICE TYPE
  230.   6.56 INDIA MARKET ANALYSIS BY CAREGIVER TYPE
  231.   6.57 INDIA MARKET ANALYSIS BY PAYMENT SOURCE
  232.   6.58 INDIA MARKET ANALYSIS BY AGE GROUP
  233.   6.59 INDIA MARKET ANALYSIS BY HEALTH CONDITION
  234.   6.60 JAPAN MARKET ANALYSIS BY SERVICE TYPE
  235.   6.61 JAPAN MARKET ANALYSIS BY CAREGIVER TYPE
  236.   6.62 JAPAN MARKET ANALYSIS BY PAYMENT SOURCE
  237.   6.63 JAPAN MARKET ANALYSIS BY AGE GROUP
  238.   6.64 JAPAN MARKET ANALYSIS BY HEALTH CONDITION
  239.   6.65 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
  240.   6.66 SOUTH KOREA MARKET ANALYSIS BY CAREGIVER TYPE
  241.   6.67 SOUTH KOREA MARKET ANALYSIS BY PAYMENT SOURCE
  242.   6.68 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
  243.   6.69 SOUTH KOREA MARKET ANALYSIS BY HEALTH CONDITION
  244.   6.70 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE
  245.   6.71 MALAYSIA MARKET ANALYSIS BY CAREGIVER TYPE
  246.   6.72 MALAYSIA MARKET ANALYSIS BY PAYMENT SOURCE
  247.   6.73 MALAYSIA MARKET ANALYSIS BY AGE GROUP
  248.   6.74 MALAYSIA MARKET ANALYSIS BY HEALTH CONDITION
  249.   6.75 THAILAND MARKET ANALYSIS BY SERVICE TYPE
  250.   6.76 THAILAND MARKET ANALYSIS BY CAREGIVER TYPE
  251.   6.77 THAILAND MARKET ANALYSIS BY PAYMENT SOURCE
  252.   6.78 THAILAND MARKET ANALYSIS BY AGE GROUP
  253.   6.79 THAILAND MARKET ANALYSIS BY HEALTH CONDITION
  254.   6.80 INDONESIA MARKET ANALYSIS BY SERVICE TYPE
  255.   6.81 INDONESIA MARKET ANALYSIS BY CAREGIVER TYPE
  256.   6.82 INDONESIA MARKET ANALYSIS BY PAYMENT SOURCE
  257.   6.83 INDONESIA MARKET ANALYSIS BY AGE GROUP
  258.   6.84 INDONESIA MARKET ANALYSIS BY HEALTH CONDITION
  259.   6.85 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE
  260.   6.86 REST OF APAC MARKET ANALYSIS BY CAREGIVER TYPE
  261.   6.87 REST OF APAC MARKET ANALYSIS BY PAYMENT SOURCE
  262.   6.88 REST OF APAC MARKET ANALYSIS BY AGE GROUP
  263.   6.89 REST OF APAC MARKET ANALYSIS BY HEALTH CONDITION
  264.   6.90 SOUTH AMERICA MARKET ANALYSIS
  265.   6.91 BRAZIL MARKET ANALYSIS BY SERVICE TYPE
  266.   6.92 BRAZIL MARKET ANALYSIS BY CAREGIVER TYPE
  267.   6.93 BRAZIL MARKET ANALYSIS BY PAYMENT SOURCE
  268.   6.94 BRAZIL MARKET ANALYSIS BY AGE GROUP
  269.   6.95 BRAZIL MARKET ANALYSIS BY HEALTH CONDITION
  270.   6.96 MEXICO MARKET ANALYSIS BY SERVICE TYPE
  271.   6.97 MEXICO MARKET ANALYSIS BY CAREGIVER TYPE
  272.   6.98 MEXICO MARKET ANALYSIS BY PAYMENT SOURCE
  273.   6.99 MEXICO MARKET ANALYSIS BY AGE GROUP
  274.   6.100 MEXICO MARKET ANALYSIS BY HEALTH CONDITION
  275.   6.101 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE
  276.   6.102 ARGENTINA MARKET ANALYSIS BY CAREGIVER TYPE
  277.   6.103 ARGENTINA MARKET ANALYSIS BY PAYMENT SOURCE
  278.   6.104 ARGENTINA MARKET ANALYSIS BY AGE GROUP
  279.   6.105 ARGENTINA MARKET ANALYSIS BY HEALTH CONDITION
  280.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
  281.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY CAREGIVER TYPE
  282.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PAYMENT SOURCE
  283.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
  284.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY HEALTH CONDITION
  285.   6.111 MEA MARKET ANALYSIS
  286.   6.112 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE
  287.   6.113 GCC COUNTRIES MARKET ANALYSIS BY CAREGIVER TYPE
  288.   6.114 GCC COUNTRIES MARKET ANALYSIS BY PAYMENT SOURCE
  289.   6.115 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
  290.   6.116 GCC COUNTRIES MARKET ANALYSIS BY HEALTH CONDITION
  291.   6.117 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE
  292.   6.118 SOUTH AFRICA MARKET ANALYSIS BY CAREGIVER TYPE
  293.   6.119 SOUTH AFRICA MARKET ANALYSIS BY PAYMENT SOURCE
  294.   6.120 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
  295.   6.121 SOUTH AFRICA MARKET ANALYSIS BY HEALTH CONDITION
  296.   6.122 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE
  297.   6.123 REST OF MEA MARKET ANALYSIS BY CAREGIVER TYPE
  298.   6.124 REST OF MEA MARKET ANALYSIS BY PAYMENT SOURCE
  299.   6.125 REST OF MEA MARKET ANALYSIS BY AGE GROUP
  300.   6.126 REST OF MEA MARKET ANALYSIS BY HEALTH CONDITION
  301.   6.127 KEY BUYING CRITERIA OF PHARMACEUTICAL
  302.   6.128 RESEARCH PROCESS OF MRFR
  303.   6.129 DRO ANALYSIS OF PHARMACEUTICAL
  304.   6.130 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  305.   6.131 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  306.   6.132 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  307.   6.133 PHARMACEUTICAL, BY SERVICE TYPE, 2024 (% SHARE)
  308.   6.134 PHARMACEUTICAL, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
  309.   6.135 PHARMACEUTICAL, BY CAREGIVER TYPE, 2024 (% SHARE)
  310.   6.136 PHARMACEUTICAL, BY CAREGIVER TYPE, 2024 TO 2035 (USD Billion)
  311.   6.137 PHARMACEUTICAL, BY PAYMENT SOURCE, 2024 (% SHARE)
  312.   6.138 PHARMACEUTICAL, BY PAYMENT SOURCE, 2024 TO 2035 (USD Billion)
  313.   6.139 PHARMACEUTICAL, BY AGE GROUP, 2024 (% SHARE)
  314.   6.140 PHARMACEUTICAL, BY AGE GROUP, 2024 TO 2035 (USD Billion)
  315.   6.141 PHARMACEUTICAL, BY HEALTH CONDITION, 2024 (% SHARE)
  316.   6.142 PHARMACEUTICAL, BY HEALTH CONDITION, 2024 TO 2035 (USD Billion)
  317.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  318. 7 LIST OF TABLES
  319.   7.1 LIST OF ASSUMPTIONS
  320.     7.1.1
  321.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  322.     7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  323.     7.2.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  324.     7.2.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  325.     7.2.4 BY AGE GROUP, 2025-2035 (USD Billion)
  326.     7.2.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  327.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  328.     7.3.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  329.     7.3.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  330.     7.3.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  331.     7.3.4 BY AGE GROUP, 2025-2035 (USD Billion)
  332.     7.3.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  333.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  334.     7.4.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  335.     7.4.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  336.     7.4.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  337.     7.4.4 BY AGE GROUP, 2025-2035 (USD Billion)
  338.     7.4.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  339.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  340.     7.5.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  341.     7.5.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  342.     7.5.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  343.     7.5.4 BY AGE GROUP, 2025-2035 (USD Billion)
  344.     7.5.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  345.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  346.     7.6.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  347.     7.6.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  348.     7.6.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  349.     7.6.4 BY AGE GROUP, 2025-2035 (USD Billion)
  350.     7.6.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  351.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  352.     7.7.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  353.     7.7.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  354.     7.7.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  355.     7.7.4 BY AGE GROUP, 2025-2035 (USD Billion)
  356.     7.7.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  357.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  358.     7.8.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  359.     7.8.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  360.     7.8.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  361.     7.8.4 BY AGE GROUP, 2025-2035 (USD Billion)
  362.     7.8.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  363.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  364.     7.9.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  365.     7.9.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  366.     7.9.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  367.     7.9.4 BY AGE GROUP, 2025-2035 (USD Billion)
  368.     7.9.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  369.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  370.     7.10.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  371.     7.10.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  372.     7.10.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  373.     7.10.4 BY AGE GROUP, 2025-2035 (USD Billion)
  374.     7.10.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  375.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  376.     7.11.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  377.     7.11.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  378.     7.11.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  379.     7.11.4 BY AGE GROUP, 2025-2035 (USD Billion)
  380.     7.11.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  381.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  382.     7.12.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  383.     7.12.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  384.     7.12.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  385.     7.12.4 BY AGE GROUP, 2025-2035 (USD Billion)
  386.     7.12.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  387.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  388.     7.13.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  389.     7.13.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  390.     7.13.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  391.     7.13.4 BY AGE GROUP, 2025-2035 (USD Billion)
  392.     7.13.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  393.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  394.     7.14.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  395.     7.14.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  396.     7.14.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  397.     7.14.4 BY AGE GROUP, 2025-2035 (USD Billion)
  398.     7.14.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  399.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  400.     7.15.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  401.     7.15.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  402.     7.15.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  403.     7.15.4 BY AGE GROUP, 2025-2035 (USD Billion)
  404.     7.15.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  405.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  406.     7.16.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  407.     7.16.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  408.     7.16.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  409.     7.16.4 BY AGE GROUP, 2025-2035 (USD Billion)
  410.     7.16.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  411.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  412.     7.17.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  413.     7.17.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  414.     7.17.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  415.     7.17.4 BY AGE GROUP, 2025-2035 (USD Billion)
  416.     7.17.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  417.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  418.     7.18.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  419.     7.18.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  420.     7.18.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  421.     7.18.4 BY AGE GROUP, 2025-2035 (USD Billion)
  422.     7.18.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  423.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  424.     7.19.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  425.     7.19.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  426.     7.19.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  427.     7.19.4 BY AGE GROUP, 2025-2035 (USD Billion)
  428.     7.19.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  429.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  430.     7.20.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  431.     7.20.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  432.     7.20.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  433.     7.20.4 BY AGE GROUP, 2025-2035 (USD Billion)
  434.     7.20.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  435.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  436.     7.21.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  437.     7.21.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  438.     7.21.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  439.     7.21.4 BY AGE GROUP, 2025-2035 (USD Billion)
  440.     7.21.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  441.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  442.     7.22.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  443.     7.22.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  444.     7.22.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  445.     7.22.4 BY AGE GROUP, 2025-2035 (USD Billion)
  446.     7.22.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  447.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  448.     7.23.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  449.     7.23.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  450.     7.23.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  451.     7.23.4 BY AGE GROUP, 2025-2035 (USD Billion)
  452.     7.23.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  453.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  454.     7.24.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  455.     7.24.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  456.     7.24.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  457.     7.24.4 BY AGE GROUP, 2025-2035 (USD Billion)
  458.     7.24.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  459.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  460.     7.25.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  461.     7.25.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  462.     7.25.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  463.     7.25.4 BY AGE GROUP, 2025-2035 (USD Billion)
  464.     7.25.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  465.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  466.     7.26.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  467.     7.26.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  468.     7.26.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  469.     7.26.4 BY AGE GROUP, 2025-2035 (USD Billion)
  470.     7.26.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  471.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  472.     7.27.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  473.     7.27.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  474.     7.27.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  475.     7.27.4 BY AGE GROUP, 2025-2035 (USD Billion)
  476.     7.27.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  477.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  478.     7.28.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  479.     7.28.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  480.     7.28.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  481.     7.28.4 BY AGE GROUP, 2025-2035 (USD Billion)
  482.     7.28.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  483.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  484.     7.29.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  485.     7.29.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  486.     7.29.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  487.     7.29.4 BY AGE GROUP, 2025-2035 (USD Billion)
  488.     7.29.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  489.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  490.     7.30.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  491.     7.30.2 BY CAREGIVER TYPE, 2025-2035 (USD Billion)
  492.     7.30.3 BY PAYMENT SOURCE, 2025-2035 (USD Billion)
  493.     7.30.4 BY AGE GROUP, 2025-2035 (USD Billion)
  494.     7.30.5 BY HEALTH CONDITION, 2025-2035 (USD Billion)
  495.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  496.     7.31.1
  497.   7.32 ACQUISITION/PARTNERSHIP
  498.     7.32.1

Pharmaceutical Market Segmentation

Pharmaceutical By Service Type (USD Billion, 2025-2035)

  • Home Care Services
  • Adult Day Care Services
  • Nursing Care Services
  • Assisted Living Services

Pharmaceutical By Caregiver Type (USD Billion, 2025-2035)

  • Professional Caregivers
  • Family Caregivers
  • Volunteers

Pharmaceutical By Payment Source (USD Billion, 2025-2035)

  • Private Pay
  • Medicare
  • Medicaid
  • Long-term Care Insurance

Pharmaceutical By Age Group (USD Billion, 2025-2035)

  • 65-74 Years
  • 75-84 Years
  • 85 Years and Older

Pharmaceutical By Health Condition (USD Billion, 2025-2035)

  • Chronic Illness
  • Mobility Issues
  • Cognitive Impairment
  • Mental Health Issues

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions